TY - JOUR
T1 - Skin transplantation during the pre-Reverdin era, 1804-1869
AU - Balch, C. M.
AU - Marzoni, F. A.
N1 - Copyright:
Copyright 2004 Elsevier B.V., All rights reserved.
PY - 1977
Y1 - 1977
N2 - In 1869, Jacques Reverdin's classic paper describing the successful use of small, thin human skin autografts heralded an important clinical era in plastic surgery. However, the 65 years prior to this were filled with important technical and biologic development that presaged Reverdin's epochal discovery. Successful free skin autografts were performed by Baronio in 1804, Cooper in 1817, Bunger in 1823, Dieffenbach in 1833 and Warren, in 1840. More than a score of other investigators were unsuccessful with free skin grafts largely because the grafts were too large, too thick, poorly secured and unprotected from infection. In contrast, the use of delayed pedicle skin grafts permitted the successful development of numerous plastic reparative procedures. Numerous investigators, notably Dieffenbach and Bert, made important biologic observations regarding tissue transplantation and the inevitable immunologic rejection processes that ensued.
AB - In 1869, Jacques Reverdin's classic paper describing the successful use of small, thin human skin autografts heralded an important clinical era in plastic surgery. However, the 65 years prior to this were filled with important technical and biologic development that presaged Reverdin's epochal discovery. Successful free skin autografts were performed by Baronio in 1804, Cooper in 1817, Bunger in 1823, Dieffenbach in 1833 and Warren, in 1840. More than a score of other investigators were unsuccessful with free skin grafts largely because the grafts were too large, too thick, poorly secured and unprotected from infection. In contrast, the use of delayed pedicle skin grafts permitted the successful development of numerous plastic reparative procedures. Numerous investigators, notably Dieffenbach and Bert, made important biologic observations regarding tissue transplantation and the inevitable immunologic rejection processes that ensued.
UR - http://www.scopus.com/inward/record.url?scp=0017649226&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0017649226&partnerID=8YFLogxK
M3 - Article
C2 - 322349
AN - SCOPUS:0017649226
SN - 0039-6087
VL - 144
SP - 766
EP - 773
JO - Surgery Gynecology and Obstetrics
JF - Surgery Gynecology and Obstetrics
IS - 5
ER -